Daily News

Jamie Golombek: CRA is challenging perceived real estate 'flips' through the court system, with mixed results Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purch...

Canada's main stock index was up nearly 250 points Tuesday, swept up by a reversal in oil prices and broad-based gains, while U.S. markets also rose. The S&P/TSX Composite Index was up 242.88 points, or 1.22 per cent, at 20,220.01. Sign up to get bre...

The majority of Canadians prefer to invest their money in the stock market, according to a survey by HelloSafe. A report released last week asked respondents to choose their three top investment products out of seven options. It found over half of responde...

U.S. stocks rose as investors adjusted their expectations in response to Federal Reserve officials indicating that they’ll continue to raise interest rates but are open to slowing their tempo.  Sign up to get breaking news email alerts sent directly to...

Brett Girard, chief financial officer and portfolio manager, Liberty International Investment Management FOCUS: Global stocks  MARKET OUTLOOK: It is likely the market will continue to struggle for direction as we head into year-end. Inflation appea...

Good evening. I’m pleased to be here with Senior Deputy Governor Carolyn Rogers to discuss our recent policy announcement and the Bank of Canada’s Monet...

'We will fight for you and we'll go to the wall for you' Alberta Premier Danielle Smith appears to have kicked her campaign off in earnest ahead of May’s election, rolling out a $2.4-billion relief package for families struggling with living co...

This section is Presented This section was produced by the editorial department. The client was not given the opportunity to put restrictions on the content or review it prior to publication. by HSBC HSBC Episode 177 of Do...

Luckily only one infusion required of hemophilia B gene therapy U.S. regulators approved CSL Behring’s hemophilia B gene therapy, a one-off infusion that frees patients from regular treatments but costs US$3.5 million a dose, making it the most...

This section is Presented This section was produced by the editorial department. The client was not given the opportunity to put restrictions on the content or review it prior to publication. by HSBC HSBC Central banks mig...